Provenance
Developed by SPS, NHS England, the British Association of Sexual Health and HIV (BASHH), the British Association of HIV (BHIVA) and the support of specialist stakeholders working within clinical practice for sexual health services.
Scope
This PGD applies to the supply of emtricitabine/tenofovir alafenamide fumarate (TAF) as Pre-Exposure Prophylaxis (PrEP) for the prevention of sexually transmitted HIV infection in line with NHSE commissioning policy and in line with the product licence.
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice.
More sexual health PGD templates
- Emtricitabine and tenofovir disoproxil (TD) tablets as PrEP
- Doxycycline post exposure prophylaxis (doxyPEP)
- Podophyllotoxin (topical) for external anogenital warts
- Imiquimod 5% w/w cream for anogenital warts
- Aciclovir (oral) for genital HSV infection
- Fluconazole 150mg capsules for candidiasis
- Clotrimazole pessaries for candidiasis
- Clotrimazole cream for candidiasis and candidal balanoposthitis
- Ceftriaxone intramuscular injection for Neisseria gonorrhoeae
- Metronidazole (oral) for use within sexual health services
- Doxycycline for use within sexual health services
- Azithromycin (oral) for use within sexual health services
- Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
All PGD templates
National PGD templates
National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Published
- New template added